Dietary Supplement Production: A Business Guide

Admission: Polish supplement market The dietary supplement industry is one of the fastest-growing in Europe, with a value exceeding PLN 7 billion in 2024. At the same time, it's an industry burdened with significant regulatory risk. The following guide examines the key business, legal, and marketing aspects of producing and marketing dietary supplements in Poland, with particular emphasis on costs, legal requirements, and marketing pitfalls.

PART 1. Strategy and Market Analysis (2024-2025)

The Polish supplement market is mature, highly concentrated, and highly competitive. It is dominated by pharmaceutical companies such as Aflofarm, USP Zdrowie, and Olimp Laboratories. The success of new brands depends on understanding key trends and carefully analyzing entry costs.

Key Trends Shaping Demand

• Personalization: Growing demand for tailor-made products, often based on biometric or genetic testing.
• Stress Management: The growing popularity of adaptogens (e.g. ashwagandha) supporting mental health and stress reduction.
• Innovative Forms: Moving away from standard tablets towards forms with higher bioavailability (e.g. microencapsulation, nanotechnology).

Cost of Entry Analysis: Two Business Models

The barrier to entry varies drastically depending on the model chosen.

1. Model 1: Contract Manufacturing (Outsourcing)
   This is the preferred route for most new brands. The minimum initial investment (for the first batch) is in the range 30,000 – 50,000 PLNThis amount typically covers the costs of raw materials, formulation development (R&D), quality testing, and packaging design. For example, the cost of producing 2500 hard capsules of a supplement is approximately PLN 40,000–43,000 (approximately PLN 17.20/piece). This model allows us to avoid the multi-million costs of building our own plant and implementing systems. quality (GMP/HACCP).

2. Model 2: Own Production Plant
   The costs here are several orders of magnitude higher. They require investments in the construction and maintenance of cleanrooms, the purchase of professional processing lines (hundreds of thousands or even millions of PLN), and the implementation and certification of GMP and HACCP systems.

Hidden Costs (Laboratory): Regardless of the model, the current testing costs of each batch should be budgeted: e.g. heavy metals (approx. PLN 246), vitamin D (approx. PLN 395), microbiological tests (approx. PLN 22-90 per parameter) and stability tests, which are crucial for the expiry date.

Proposal: For 99% of new entrants, the only viable entry path is contract manufacturing. The PLN 30-50 fee effectively represents access to certified infrastructure and manufacturer know-how.

PART 2. Legal Foundations: The "Food" Trap

Failure to understand the legal status of a dietary supplement is the source of the most serious errors and penalties.

A Dietary Supplement is Food, Not Medicine

In Polish and EU law supplement diet is not a drug. It is uniquely defined as foodstuff (food)Its purpose is solely supplement normal diet, not the treatment or prevention of diseases.

"Legal Trap"

This status is a legal trap that defines risk in the industry:

1. Easy Entry: Drugs require years of research and expensive "marketing authorization." Supplements (as food) only require notification (notifications) of the Chief Sanitary Inspector (GIS).
2. Risky Marketing: The entrepreneur knows that consumers buy the product for its "effect." Marketing, therefore, begins to communicate the supplement's effects in a manner similar to that of a drug.
3. Intervention and Punishment: This is where regulators intervene.
   • UOKiK states: "Advertising food as a medicine is misleading. A fine of up to 10% of annual turnover." (Example: PLN 26 million fine for Aflofarm).
   • GIS states: "The dose of the active ingredient in this 'food' is so high that it qualifies as a medicinal product. We are initiating an investigation."

Surveillance Ecosystem: Three Fronts of Control

An entrepreneur must operate under the supervision of three different institutions:

1. Chief Sanitary Inspectorate (GIS)

• Domain: PRODUCT (Composition, Qualification).
• Action: Receives notifications. In case of doubt (e.g. too high a dose), initiates explanatory proceedings .
• Advisory Body: The Dietary Supplements Team operates at the Chief Sanitary Inspectorate and issues key resolutions specifying, among other things, the maximum safe doses of vitamins and plant ingredients.

2. State Sanitary Inspection (PIS / "Sanepid")

• Domain: FACILITY (Hygiene, Process).
• Action: The entrepreneur must obtain entry of the plant into the register The State Sanitary Inspectorate (PIS) controls hygiene and the implementation of GMP and HACCP systems at the plant (or contract manufacturer).

3. Office of Competition and Consumer Protection (UOKiK)

• Domain: MARKETING (Advertising, Label).
• Action: It monitors whether advertising and labeling mislead consumers. It imposes financial penalties (up to 10% of annual turnover).

PART 3. Outsourcing: Contract Manufacturing vs. Private Label

For new brands, outsourcing is the recommended model. It's crucial to distinguish between its two forms.

Contract Manufacturing (Contract Manufacturing)

Definition: The manufacturer produces the supplement according to the specifications and unique formula provided by the customer (brand) or developed in cooperation with him.
Advantages: Full control over the recipe, the ability to create an original, unique product and build a lasting competitive advantage.
Disadvantages: Higher R&D costs, higher MOQ (Minimal Order Quantity), longer time to market.

Private Label (White Label)

Definition: The brand buys from the manufacturer ready-made, standard product (developed by the manufacturer) and sells it under its own label.
Advantages: Rapid market entry, very low R&D costs (the product already exists).
Disadvantages: Lack of uniqueness. The same generic product is sold by multiple competitors, reducing the competition to a price and marketing war.

Strategic Recommendation: In the mature Polish market, where consumers are looking for innovation, the model Private Label is risky (price war). Long-term success can only be built contract production, based on a unique formula.

Key Provisions in the Contract Agreement

The contract manufacturer agreement is a key security document. Mistakes in it can cost you your brand.

• Recipe Rights (IP): The contract must clearly state that the exclusive rights to the developed formula belong to the client (brand) and it is a trade secret. Without this provision, the manufacturer can legally sell "your" recipe to competitors after the contract ends.
• Responsibility for Etiquette: It is necessary to precisely determine who bears liability for damages (civil liability) for errors on the label (the manufacturer or the brand). (Note: administrative liability to the Office of Competition and Consumer Protection/GIS always rests with the brand.)
• Scope of Research: The contract must specify the mandatory scope of testing (e.g. heavy metals, microbiology) for each batch of raw material and finished product.

PART 4. Recipe Pitfalls: Novel Food and GIS Resolutions

Designing a product's composition is the first minefield. Ingredients must be approved, their dosages safe, and compliant with the "food" classification.

Barrier 1: Novel Food

What is this? An ingredient (e.g. exotic plant extract) that was not used on a significant scale in the EU before 15 May 1997.
Risk: Such an ingredient cannot be legally placed on the market without authorization from the European Commission, which requires a lengthy and costly scientific evaluation by the EFSA. The use of an unauthorized Novel Food ingredient results in the immediate withdrawal of the product from the market.

Barrier 2: Resolutions of the Dietary Supplements Committee (GIS)

What are they? Scientific opinions of GIS experts defining maximum safe daily doses for various ingredients (e.g. vitamins, caffeine, plant ingredients).
Are they binding? Formally, they are not a source of law.
Risk (De facto binding force): Ignoring these resolutions is extremely risky. If a business notifies the Chief Sanitary Inspectorate (GIS) of a product with a dose higher than recommended in the resolution (e.g., 150 µg of B12 instead of the recommended 100 µg), GIS automatically initiates explanatory proceedings , considering that he has doubts about the safety of the product or its qualification (whether it is not a medicine).

Table 3: Sample GIS Team Resolutions (Maximum Doses)

PART 5. Marketing Procedure (Step by Step)

This process involves two key, independent submissions.

Step 1: Registering the Plant with PIS (Sanepid)

Who: Any entrepreneur introducing food (including supplements) to the market.
Co: Must be submitted application for entry of the establishment into the register of establishments subject to PIS control (this can be done electronically). This applies to the company's headquarters/warehouse from which the products are placed on the market.
When: Before starting your business.

Step 2: Product Notification in GIS

Who: Entity introducing the supplement to the market in Poland for the first time.
Co: Must be submitted notification to the Chief Sanitary Inspector. The procedure is fully digitized (via e-Sanepid or biznes.gov.pl). A sample label in Polish must be attached to the form.
When: No later than the day the product is introduced to the market.
Important: Notification is not a "permission." It merely informs the authority. Full responsibility for the product's safety and compliance rests with the entrepreneur.

Risk: GIS Investigation

If after notification the Chief Sanitary Inspectorate has any doubts (e.g. regarding the dose or ingredient), it will initiate explanatory proceedings The burden of proof then falls on the entrepreneur. The Chief Sanitary Inspectorate (GIS) may require the submission of costly scientific opinions (at the entrepreneur's expense) to prove the product's safety or its classification as food. A negative outcome (e.g., an opinion that the product is a drug) may lead to a decision to withdraw the product from the market.

PART 6. Quality Assurance (Research)

Following critical reports from the Supreme Audit Office, which revealed deficiencies in quality control, transparency in research has become a key marketing differentiator.

Compulsory Tests (Every Batch)

Each batch of finished product must be tested to confirm safety and composition.

• Chemical Contaminants: Levels of heavy metals (lead, cadmium, mercury), pesticides, PAHs.
• Microbiological Purity: Presence of bacteria, molds, fungi.
• Composition Confirmation (Potency): Analytical confirmation that the product contains exactly the amount of active ingredients (e.g. vitamins, extracts) declared on the label.

Stability Studies (Expiration Date)

Cel: Scientific confirmation of the declared expiration date. The entrepreneur must prove that the product retains its full potency (amount of ingredients) and safety throughout its shelf life, not just on the day of production.
Method: Accelerated (higher temperature) and long-term (real-time) tests in climatic chambers.

SECTION 7. Legal Liability

The golden rule of the market is: the entity introducing the product to the market (the brand whose data is on the label) bears full responsibility for the product .

In an outsourcing model, this is critical. A contract manufacturer agreement does not protect the brand from liability to consumers or government authorities.

If a defective product (e.g. contaminated) causes harm to the consumer, the defendant will be sued. brand (on a risk-based basis, regardless of fault). Only then can the brand (if it has a good contract) seek reimbursement (recourse) from the manufacturer if it proves that the defect was caused by its fault.

Proposal: Choosing the cheapest contract manufacturer is the biggest business risk. Choosing a partner with GMP certifications and a reliable quality system is crucial.

SECTION 8. Legal Marketing (Health Claims)

This is an area supervised by the Office of Competition and Consumer Protection and carries the highest risk of financial penalties.

Labeling (Label) – Formal Requirements

The label must include, among other things:

• The name "Dietary Supplement".
• Recommended daily dose and warning not to exceed it.
• The statement that the supplement it cannot be used as a substitute for a varied diet.
• Statement about storing out of reach of small children.

Health Claims

The use of claims (e.g. “supports immunity”) is strictly regulated.

1. Authorised Statements (EFSA)
These are claims from the EU register that have undergone a positive scientific evaluation by EFSA (e.g., "Vitamin C contributes to the normal function of the immune system"). Their use is safe as long as conditions (e.g., dosages) are met.

2. Pending Statements
They primarily involve botanicals. They were submitted for evaluation, but the process was halted.
Conditions of Use (according to GIS): They can be used under the entrepreneur’s responsibility, provided that:

• The statement is on the "pending" list.
• Entrepreneur must have scientific evidence (studies) confirming the declared effect and the required dose.
• The ingredient is used in the product in an amount sufficient to achieve this effect.
• The content does not suggest treating any disease.

3. Prohibited (Therapeutic) Statements
Any suggestions that the supplement cures diseases, prevents them, or refers to medical conditions are absolutely prohibited. It is also prohibited to suggest that a balanced diet is not enough.

Table 4: Examples of Health Claims

PART 9. Case Study UOKiK vs. Influencers (Olimp Laboratories Case)

In recent years, the Office of Competition and Consumer Protection has focused on law enforcement in social media, publishing "Recommendations on the marking of advertising content by influencers" in 2021.

Risk: Surreptitious advertising

Surreptitious advertising is the promotion of a product for remuneration (cash or barter) without clearly and unambiguously informing consumers about it.

Case Study: Penalty for Olimp Laboratories (2023)

This case is a milestone and evidence of a change in the regulator's approach.

• Black: The President of the Office of Competition and Consumer Protection imposed over 5 million zlotys in fines on Olimp Laboratories and financial penalties on cooperating fitness influencers (including Katarzyna Dziurska, Katarzyna Oleśkiewicz-Szuba).
• Reason: The Office of Competition and Consumer Protection found that Olimp he commissioned influencers paid publications that were not marked as advertising or were marked in a misleading way.
• Challenged Actions: The Office of Competition and Consumer Protection questioned unclear designations, such as the hashtag #olimpad suggested by the company, which were not clear to consumers.
• Position of the Office of Competition and Consumer Protection: The President of the Office of Competition and Consumer Protection clearly stated that after the period of educational activities (#OznaczamReklamy campaign) it was time for law enforcement.

The End of Responsibility Shifting

The decision in the Olimp Laboratories case proves beyond doubt that client (brand) bears direct and primary responsibility for the way its marketing activities are being labeled by a hired influencer. The Office of Competition and Consumer Protection (UOKiK) fined both parties, but the main financial burden (over PLN 5 million) fell on the brand.

Attempting to shift responsibility to the agency or the creator themselves does not protect the brand from punishment if the Office of Competition and Consumer Protection (UOKiK) deems it an organizer of the practice. For the entrepreneur, this means that the contract with the influencer musi contain precise, binding provisions obliging it to use precise markings consistent with the UOKiK Recommendations. Furthermore, the brand must actively monitor execution of these records.

Table 5: Good and Bad Supplement Advertising Practices (Do's and Don'ts)

PART 10. Conclusion: The Future of the Market Belongs to the Honest

The dietary supplement market in Poland will continue to grow, driven by strong health-promoting trends and personalization. However, the "Wild West era" of marketing, highlighted in reports by the Supreme Audit Office (NIK) and brutally curtailed by interventions by the Office of Competition and Consumer Protection (UOKiK), has definitively ended.

In the current regulatory landscape, only those entities that can combine three pillars will succeed:

• Product Innovation (personalization, bioavailability, unique formulas).
• Radical Transparency (e.g. making qualitative research publicly available).
• Iron Regulatory Discipline (proactive compliance with GIS and UOKiK guidelines).

Final Conclusion: The cost of compliance has ceased to be an add-on or administrative expense. It has become an integral and strategic part of the dietary supplement industry's business model.

Bibliography and Useful Links (Works Cited)

The list below contains the sources cited in this guide. 

• 1. Dietary supplements market in Poland – trends in 2024 and prospects for 2025 (DI mobile)
• 2. The state has declared war on dietary supplement advertising. Aflofarm faces a hefty fine (Money.pl)
• 3. USP Zdrowie dietary supplement review (Ceneo.pl)
• 4. USP Zdrowie brand products (New Pharmacy Pharmacy)
• 5. USP Zdrowie Brand Portfolio (USP Zdrowie Official Website)
• 6. The Office of Competition and Consumer Protection imposed a PLN 5 million fine on Olimp Laboratories and influencers (Cosmetics News)
• 7. PLN 5 million fine for surreptitious advertising – analysis of the decision of the President of the Office of Competition and Consumer Protection (Kancelaria Czyżewscy)
• 8. Why are more words allowed in dietary supplement advertising than in drug advertising? (MedExpress)
• 9. Actual Production Costs of Dietary Supplements – Analysis and Strategies (ProdukcjaSuplementow.pl)
• 10. Cost of producing dietary supplements – price list (IOC)
• 11. Understanding Contract Manufacturing of Dietary Supplements (Yellow Emperor)
• 12. Minimum Order Quantity (MOQ) – Meaning and Calculation (Product Fulfilment Solutions)
• 13. CLEANROOM – rules of work in clean rooms (e-bioadvice)
• 14. Manual capsule filling machine (Ceneo.pl)
• 15. Capsule filling machines in the Empty Capsules category (Allegro.pl)
• 16. Capsule Filling Machine (Allegro.pl)
• 17. Manual Capsule Filler (Swiss Herbal Shop)
• 18. Production of dietary supplements – requirements and regulations (Eubioco)
• 19. GHP/GMP principles and the HACCP system – Guide for entrepreneurs (WSSE Gorzów)
• 20. Dietary Supplement Testing – Price List (GBA Polska)
• 21. Price list for laboratory services (WSSE Kraków)
• 22. Price lists – Microbiological food testing (WIW Bydgoszcz)
• 23. Supplement Stability Tests – How Durability and Safety Are Tested (Pharma Dot)
• 24. Notification of product introduction to the market (e-Sanepid)
• 25. Obtain an entry in the register of establishments subject to the control of the State Sanitary Inspectorate (Biznes.gov)
• 26. How to advertise dietary supplements? Advertising rules (Creativa Legal)
• 27. Act on Food and Nutrition Safety (Journal of Laws 2023, item 1448)
• 28. Step by step: How to properly notify dietary supplements to GIS? (Komorowice.pl)
• 29. NIK Report: Marketing Authorisation of Dietary Supplements (NIK)
• 30. How to legally report a dietary supplement to GIS? (RPMS Office)
• 31. GIS experts on market organization and resolutions of the Dietary Supplements Team (PAP)
• 32. What is the explanatory procedure during the notification of a dietary supplement? (Zboralska Law Firm)
• 33. How does the registration (notification) of dietary supplements in GIS work? (Tantus)
• 34. First marketing notification form (Gov.pl)
• 35. Can the outcome of the explanatory proceedings before the Chief Sanitary Inspectorate be questioned? (Food-law.pl)
• 36. GIS determined the maximum content of, among others, vitamin B12, caffeine, iodine (CHPL)
• 37. GIS resolutions on dietary supplements: binding power and maximum doses (CHWP)
• 38. Dietary supplements – registration and approval of the plant (Gov.pl)
• 39. Application for entry of the establishment into the register of establishments (e-Sanepid)
• 40. UOKiK inspections in social media – how to advertise dietary supplements (RDhub)
• 41. Novel Food – Explanation (EFSA)
• 42. EFSA: new guidelines for novel food applications (FoodFakty)
• 43. Health claims from the so-called "pending list" – conditions of use (Gov.pl – GIS)
• 44. Contract manufacturing of dietary supplements – overview (ProdukcjaSuplementow.pl)
• 45. Contract manufacturing of supplements (IOC)
• 46. Contract manufacturing vs. private label – a comparison (Eubioco)
• 47. What is contract manufacturing of dietary supplements? (Exim Pharma)
• 48. Errors in contracts for contract manufacturing of supplements (Lawyer Konstancin)
• 49. Contract Manufacturing Agreement – ​​A Guide for E-Commerce (Creativa Legal)
• 50. Optimization of production costs of dietary supplements (Eubioco)
• 51. Physicochemical tests of supplements (JS Hamilton Poland)
• 52. Regulation on the composition and labeling of dietary supplements (Journal of Laws 2023, item 79)
• 53. New guidelines on vitamin B6 intake (DOZ.pl)
• 54. Do I have to provide opinions from scientific institutions during the investigation? (Zboralska Law Firm)
• 55. The Importance of the Resolutions of the Fairfield Dietary Supplements Panel
• 56. List of 10 banned substances in supplements (Food-law.pl)
• 57. Further plant ingredients restricted by resolutions of the Team (Food-law.pl)
• 58. GIS notification template (Gov.pl)
• 59. How to Produce a Dietary Supplement? A Comprehensive Guide (ProducentSuplementow.pl)
• 60. Registration of dietary supplements and introduction to the Polish market (ProducentSuplementow.pl)
• 61. Notification of the first introduction of a food product to the market (Biznes.gov)
• 62. There will be no better quality control of supplements (Prawo.pl)
• 63. Raw materials research (Jagiellonian Innovation Centre)
• 64. Microbiological testing of dietary supplements (Mikrolab Laboratory)
• 65. We care about quality – tested products (SFD Store)
• 66. Dietary Supplement Stability Studies (JS Hamilton)
• 67. Civil liability for damage caused by functional foods (Section. Law Studies)
• 68. Dangerous Product Liability (DPL)
• 69. How to advertise dietary supplements online? (iCEA Group)
• 70. Supplements on social media - how to communicate them legally? (Beeffective)
• 71. The Office of Competition and Consumer Protection (UOKiK) charges fitness influencers for Instagram posts (Business Insider)
• 72. The Office of Competition and Consumer Protection (UOKiK) fined Olimp Laboratories and influencers PLN 5 million for surreptitious advertising (Wirtualne Media)